Hongliang Chen

6PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 18, 2025
Validation of the important role and prognostic value of KIF14 in triple-negative breast cancer.

Jingjing Yuan, Meilin Zhang, Yaxuan Liu

|Jan 12, 2024
Chemotherapy is of prognostic significance to metaplastic breast cancer.

Meilin Zhang, Jingjing Yuan, Maoli Wang

|Jun 29, 2023
The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2- Breast Cancer.

Maoli Wang, Mingdi Zhang, Hongliang Chen

|Oct 06, 2022
CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer.

Mingdi Zhang, Kejin Wu, Maoli Wang

|Apr 26, 2019
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysis.

Maoli Wang, Hongliang Chen, Kejin Wu

|Oct 27, 2017
Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.

Hongliang Chen, Kejin Wu, Maoli Wang

Pageof 1

Frequent Collaborators

1 joint publications

Mingdi Zhang

1 joint publications

Maoli Wang